Porex is the leading global developer, manufacturer, and distributor of sintered polymers. The company primarily serves healthcare end markets and also supports high-performance applications in the consumer and industrial sectors. Porex products serve filtration, venting, wicking, diffusion, and media support functions in applications such as blood filters, catheter vents, fuel filters, writing instrument tips, and consumable diagnostic tests. Porex is the primary industry innovator and leverages its strong customer relationships and deep materials science expertise to create high value-added, low cost, consumable components that are typically the key functional element in its customers' products. Porex, which pioneered sintered polymer technology 50 years ago, is today widely recognized for its materials science expertise and proprietary designs, which serve over 2,300 accounts across more than 60 countries via operations in North America, Europe, and Asia.
Date of Investment: October 2009
Date of Exit: November 2013
Type of Exit: Sale to Strategic Buyer
Headquarters: Fairburn, GA